Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B0TX
|
||||
Former ID |
DNC008812
|
||||
Drug Name |
8-bromo-9-isobutyl-9H-purin-6-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530966] | ||
Structure |
Download2D MOL |
||||
Formula |
C9H12BrN5
|
||||
Canonical SMILES |
CC(C)CN1C2=C(C(=NC=N2)N)N=C1Br
|
||||
InChI |
1S/C9H12BrN5/c1-5(2)3-15-8-6(14-9(15)10)7(11)12-4-13-8/h4-5H,3H2,1-2H3,(H2,11,12,13)
|
||||
InChIKey |
RLPKQFORPDRBQT-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [530966] | |
Adenosine A2b receptor | Target Info | Inhibitor | [530966] | ||
Adenosine A2a receptor | Target Info | Inhibitor | [530966] | ||
Adenosine A1 receptor | Target Info | Inhibitor | [530966] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Alcoholismhsa04015:Rap1 signaling pathway | |||||
cAMP signaling pathway | |||||
Parkinson's disease | |||||
Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Morphine addiction | |||||
Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.